BridgeBio Pharma vs Mirum Pharmaceuticals
BBIO and MIRM side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BBIO and MIRM compare
BridgeBio Pharma is the larger company, worth 2.5 times as much as Mirum Pharmaceuticals ($15.3B against $6.1B).
BridgeBio Pharma grew revenue faster over the last twelve months (167% versus 44.0% for Mirum Pharmaceuticals).
Mirum Pharmaceuticals scores higher on the StockData Score (5 against 3 for BridgeBio Pharma), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BBIO | MIRM |
|---|---|---|
| Size and price | ||
| Market cap | $15.3B | $6.1B |
| Share price | $78.30 | $93.99 |
| Change, 1 year | 18.2% | 32.8% |
| Change, 5 years | 83.6% | 499% |
| Beta (5Y) | 1.11 | 0.63 |
| Employees | 834 | 372 |
| StockData Score | ||
| Total score | 3 | 5 (better) |
| Valuation score | 0 | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 1 | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 16.1× | 9.9× (better) |
| FCF yield | −2.4% (better) | −3.7% |
| Growth | ||
| Revenue growth (TTM) | 167% (better) | 44.0% |
| Revenue growth, 5Y average | 127% | – |
| Profitability | ||
| Gross margin | 94.3% | – |
| Operating margin | −38.5% (better) | −135% |
| Net margin | – | −139% |
| FCF margin | −39.1% | −37.0% (better) |
| Return on equity | – | −703% |
| Financial health | ||
| Interest coverage | −7.1× (better) | −62.1× |
| Current ratio | 2.09 | 2.86 (better) |
| Altman Z-score | 0.16 (better) | −0.14 |
| Piotroski F-score | – | 5 |
| Dividends and buybacks | ||
| Buyback yield | 1.7% | – |
| Shareholder yield | 1.7% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 99.4% | 110% |
| Held by insiders | 35.6% | 9.2% |
| Insider net buying, 12 months | −$84.8M | −$31.5M (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 16.6% | 11.1% |
Go deeper
- BBIO stock overview
- BBIO income statement
- BBIO valuation and score
- MIRM stock overview
- MIRM income statement
- MIRM valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.